Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Employees

129

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26-07-03	ILA 4,750.00	+1.54%	45,975
26-07-02	ILA 4,678.00	+1.70%	52,730
26-07-01	ILA 4,600.00	0.00%	40,259
26-06-30	ILA 4,600.00	+4.62%	119,075
26-06-29	ILA 4,397.00	+1.99%	92,728

Delayed Quote TEL AVIV STOCK EXCHANGE

More quotes

Income Statement and Estimates

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 06:44:07 2026-07-03 EDT			5-day change	1st Jan Change
4,750.00 ^ILa	+1.54%		+10.18%	+52.00%

06-29	Brainsway Ltd. Presents Positive Data From Largest Real-World Study Of Deep TMS In Patients With Comorbid PTSD And Major Depressive Disorder	CI
06-09	BrainsWay Presents First SWIFT Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting	CI

Market Cap	626M 0 547M 503M 469M 889M 59.61B 903M 6.04B 2.35B 29.3B 2.35B 2.3B 101B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	626M 0 547M 503M 469M 889M 59.61B 903M 6.04B 2.35B 29.3B 2.35B 2.3B 101B	EV / Sales 2026 *	9.19x	EV / Sales 2027 *	7.37x
Free-Float	90.5%	Yield 2026 *	-	Yield 2027 *	-

06-29	Brainsway Ltd. Presents Positive Data From Largest Real-World Study Of Deep TMS In Patients With Comorbid PTSD And Major Depressive Disorder	CI
06-09	BrainsWay Presents First SWIFT Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting	CI
05-18	Hopemark Health, Ltd announced that it expects to receive funding from BrainsWay Ltd.	CI
05-18	Brainsway announces minority-stake investment in Hopemark Health	RE
05-18	BrainsWay Takes Minority Stake in Hopemark Health	MT
05-13	BrainsWay Ltd., Q1 2026 Earnings Call, May 13, 2026
05-13	BrainsWay Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-13	Brainsway Ltd. Reiterates Earnings Guidance for the Year 2026	CI
03-26	Brainsway Provides $6 Million Milestone-Based Convertible Loan to Neurolief	MT
03-19	Brainsway Pays $1 Million Milestone Payment to Axis Management	MT
03-18	Axis Management Company, Inc. announced that it has received $3.3 million in funding from BrainsWay Ltd.	CI
03-11	BrainsWay Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
03-11	BrainsWay Ltd., Q4 2025 Earnings Call, Mar 11, 2026

11-13	BrainsWay Ltd. Receives FDA Clearance of Deep TMS as Adjunct Therapy for Major Depressive Disorder in Adolescents Aged 15 to 21	CI
25-05-14	Oppenheimer Adjusts Brainsway Price Target to $15 From $13, Maintains Outperform Rating	MT
24-05-09	Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	MT
24-05-09	HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	MT
23-11-16	Oppenheimer Adjusts Price Target on Brainsway to $6 From $5.50, Maintains Outperform Rating	MT

BrainsWay Ltd. Stock

Stocks

BWAY

IL0011007189

Advanced Medical Equipment & Technology

Valuation: BrainsWay Ltd.

Chart: BrainsWay Ltd.

Latest news : BrainsWay Ltd.

Last Transcript: BrainsWay Ltd.

Analysts' recommendations: BrainsWay Ltd.

Press Releases: BrainsWay Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: BrainsWay Ltd.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Quarterly revenue - Rate of surprise

06-29	BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder	AQ
06-22	BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives	AQ
06-09	BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting	AQ
05-18	BrainsWay Announces Minority-Stake Investment in Hopemark Health	AQ
05-14	BrainsWay : Q4 2025	PU

1 day	+1.54%
1 week	+10.18%
Current month	+3.26%
1 month	+17.87%
3 months	+10.54%
6 months	+48.25%
Current year	+52.00%

1 week	4,270	4,800
1 month	3,892	4,800
Current year	3,080	5,123
1 year	1,962	5,123
3 years	386	5,123
5 years	272	5,123
10 years	272	5,123

Manager	Title	Age	Since
Hadar Levy CEO	Chief Executive Officer	54	2023-02-12
Yiftach Roth CTO	Chief Tech/Sci/R&D Officer	56	2006-04-30
Ido Marom DFI	Director of Finance/CFO	50	2023-05-22

Director	Title	Age	Since
David Zacut CHM	Chairman	74	2002-12-31
Avner Hagai BRD	Director/Board Member	70	2006-10-31
Abraham Zangen BRD	Director/Board Member	56	2019-06-16

Date	Insider	Type	Main position	Quantity	% Market Cap.
06-14	Gilead Moiseyev	Sell	Chief Technology Officer	-5,000	0.0125%
06-01	Yiftach Roth	Sell	Founder	-3,000	0.0075%
05-25	Eti Mitrany	Sell	Director	-7,980	0.0399%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BRAINSWAY LTD.	+1.54%	+10.18%	+114.83%	+1,077.49%	626M
THERMO FISHER SCIENTIFIC, INC.	+0.64%	+3.50%	+22.37%	+0.32%	195B
INTUITIVE SURGICAL, INC.	+0.23%	+6.59%	-21.20%	+24.59%	151B
DANAHER CORPORATION	+2.17%	+2.44%	-2.26%	-17.53%	140B
BOSTON SCIENTIFIC CORPORATION	+4.83%	+2.13%	-56.44%	-16.55%	67.09B
EDWARDS LIFESCIENCES CORPORATION	+2.59%	+5.18%	+22.53%	+0.04%	54.34B
SIEMENS HEALTHINEERS AG	+0.03%	+2.19%	-25.48%	-31.00%	44.64B
AGILENT TECHNOLOGIES, INC.	-0.85%	-3.56%	+8.31%	+8.68%	36.91B
WATERS CORPORATION	+0.31%	+0.64%	+7.78%	+42.30%	37.24B
GE HEALTHCARE TECHNOLOGIES INC.	-0.14%	+0.96%	-13.87%	-19.29%	29.82B
Average	+1.25%	+2.61%	+5.66%	+106.91%	75.62B
Weighted average by Cap.	+1.52%	+3.36%	-3.45%	+1.08%

	2026 *	2027 *
Net sales	68.15M 0 59.58M 54.75M 51.03M 96.8M 6.49B 98.26M 657M 256M 3.19B 256M 250M 10.99B	84.98M 0 74.29M 68.27M 63.64M 121M 8.09B 123M 820M 319M 3.98B 319M 312M 13.71B
Net income	13.23M 0 11.57M 10.63M 9.91M 18.79M 1.26B 19.08M 128M 49.61M 619M 49.67M 48.6M 2.13B	22.2M 0 19.41M 17.84M 16.63M 31.54M 2.11B 32.02M 214M 83.25M 1.04B 83.34M 81.55M 3.58B
Net Debt	-	-